Garry, D. J., Weiner, J. I., Greising, S. M., Garry, M. G., & Sachs, D. H. (2022). Mechanisms and strategies to promote cardiac xenotransplantation. Journal of Molecular and Cellular Cardiology, 172, 109–119. https://doi.org/10.1016/j.yjmcc.2022.07.013

Stanford, N. T., McAllister, J., Gibbons, M., Jensen, K., Lee, H., Rothkopf, A., Jackson, R., Farr, M., Addonizio, L., Law, S., Lee, T., Richmond, M., & Zuckerman, W. (2022). Quality of life and lifetime achievement in adult survivors of pediatric heart transplant. Pediatric Transplantation, 26(7). Portico. https://doi.org/10.1111/petr.14370

Rubinstein, G., Lotan, D., Moeller, C. M., DeFilippis, E. M., Slomovich, S., Oren, D., Yuzefpolskaya, M., Sayer, G., & Uriel, N. (2022). Sex differences in patients undergoing heart transplantation and LVAD therapy. Expert Review of Cardiovascular Therapy, 20(11), 881–894. https://doi.org/10.1080/14779072.2022.2149493

Joong, A., Zuckerman, W. A., Koehl, D., Cantor, R., Alejos, J. C., Ameduri, R. K., Boyle, G. J., Rothkopf, A. C., Kirklin, J. K., & Gajarski, R. J. (2022). Outcomes of infants with pulmonary atresia with intact ventricular septum listed for heart transplantation: A multi‐institutional study. Pediatric Transplantation, 26(7). Portico. https://doi.org/10.1111/petr.14338

Clerkin, K. J., Topkara, V. K., Farr, M. A., Jain, R., Colombo, P. C., Restaino, S., Sayer, G., Castillo, M., Lam, E. Y., Chernovolenko, M., Yuzefpolskaya, M., DeFilippis, E., Latif, F., Zorn, E., Takeda, K., Johnson, L. L., Uriel, N., & Einstein, A. J. (2022). Noninvasive Physiologic Assessment of Cardiac Allograft Vasculopathy Is Prognostic for Post-Transplant Events. Journal of the American College of Cardiology, 80(17), 1617–1628. https://doi.org/10.1016/j.jacc.2022.08.751

Garry, D. J., Weiner, J. I., Greising, S. M., Garry, M. G., & Sachs, D. H. (2022). Cardiac Xenotransplantation: Clinical Impact of Science and Discovery. Circulation, 146(13), 961–963. https://doi.org/10.1161/circulationaha.122.059191

Kampaktsis, P. N., Doulamis, I. P., Asleh, R., Makri, E., Kalamaras, I., Papastergiopoulos, C., Emfietzoglou, M., Drosou, A., Van den Eynde, J., Alnsasra, H., Duque, E. R., & Briasoulis, A. (2022). Characteristics, Predictors, and Outcomes of Early mTOR Inhibitor Use After Heart Transplantation: Insights From the UNOS Database. Journal of the American Heart Association, 11(17). https://doi.org/10.1161/jaha.122.025507

Kainuma, A., Ning, Y., Kurlansky, P. A., Wang, A. S., Latif, F., Sayer, G. T., Uriel, N., Kaku, Y., Naka, Y., & Takeda, K. (2022). Predictors of 1‐year outcome after cardiac re‐transplantation: Machine learning analysis. Clinical Transplantation, 36(9). Portico. https://doi.org/10.1111/ctr.14761

Oren, D., Zilinyi, R., Lotan, D., Uriel, M., Uriel, N., & Sayer, G. (2022). The role of temporary mechanical circulatory support as a bridge to advanced heart failure therapies or recovery. Current Opinion in Cardiology, 37(5), 394–402. https://doi.org/10.1097/hco.0000000000000976

Braghieri, L., Jennings, D. L., Bohn, B., Habal, M., Pinsino, A., Mondellini, G. M., Ladanyi, A., Latif, F., Clerkin, K., Restaino, S., Kurlansky, P., Takeda, K., Naka, Y., Demmer, R. T., Sayer, G. T., Uriel, N., Colombo, P. C., & Yuzefpolskaya, M. (2022). Temporal shifts in safety and efficacy profile of mycophenolate mofetil 2 g versus 3 g daily early after heart transplantation. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 42(9), 697–706. Portico. https://doi.org/10.1002/phar.2724

Kainuma, A., Ning, Y., Kurlansky, P. A., Wang, A. S., Latif, F., Farr, M. A., Sayer, G. T., Uriel, N., Takayama, H., Naka, Y., & Takeda, K. (2022). Deep vein thrombosis and pulmonary embolism after heart transplantation. Clinical Transplantation, 36(7). Portico. https://doi.org/10.1111/ctr.14705

DEFILIPPIS, E. M., TRUBY, L. K., CLERKIN, K. J., DONALD, E., SINNENBERG, L., VARSHNEY, A. S., COGSWELL, R., KITTLESON, M. M., HAYTHE, J. H., GIVERTZ, M. M., HSICH, E. M., AGARWAL, R., TOPKARA, V. K., & FARR, M. (2022). Increased Opportunities for Transplantation for Women in the New Heart Allocation System. Journal of Cardiac Failure, 28(7), 1149–1157. https://doi.org/10.1016/j.cardfail.2022.03.354

Mangiola, M., Ellison, M. A., Marrari, M., Bentlejewski, C., Sadowski, J., Zern, D., Niemann, M., Feingold, B., Webber, S. A., & Zeevi, A. (2022). Immunologic risk stratification of pediatric heart transplant patients by combining HLAMatchmaker and PIRCHE-II. The Journal of Heart and Lung Transplantation, 41(7), 952–960. https://doi.org/10.1016/j.healun.2022.03.015

PETTY, M. G., WU, T., ANDREI, A. C., BALDRIDGE, A., WARZECHA, A., KAO, A., SPERTUS, J., HSICH, E., DEW, M. A., PHAM, D., YANCY, C., HARTUPEE, J., COTTS, W., PAMBOUKIAN, S. V., PAGANI, F., LAMPERT, B., JOHNSON, M., MURRAY, M., TEKEDA, K., … GRADY, K. L. (2022). Baseline Quality-of-Life of Caregivers of Patients With Heart Failure Prior to Advanced Therapies: Findings From the Sustaining Quality of Life of the Aged: Transplant or Mechanical Support (SUSTAIN-IT) Study. Journal of Cardiac Failure, 28(7), 1137–1148. https://doi.org/10.1016/j.cardfail.2022.03.358

Thangappan, K., Haney, L. C., Riggs, K., Chen, S., Mehegan, M., VanderPluym, C., Woods, R., LaPar, D., Lorts, A., Zafar, F., & Morales, D. L. S. (2022). Children who stroke on VAD support: When is it safe to transplant and what are their outcomes? Artificial Organs, 46(7), 1389–1398. Portico. https://doi.org/10.1111/aor.14194

Deshpande, S. R., Zangwill, S. D., Kindel, S. J., Schroder, J. N., Bichell, D. P., Wigger, M. A., Richmond, M. E., Knecht, K. R., Pahl, E., Gaglianello, N. A., Mahle, W. T., Stamm, K. D., Simpson, P. M., Dasgupta, M., Zhang, L., North, P. E., Tomita‐Mitchell, A., & Mitchell, M. E. (2022). Relationship between donor fraction cell‐free DNA and clinical rejection in heart transplantation. Pediatric Transplantation, 26(4). Portico. https://doi.org/10.1111/petr.14264

DeFilippis, E. M., Blumer, V., Mentz, R. J., Agarwal, R., Haythe, J. H., & Kittleson, M. (2022). In-Hospital Outcomes in Pregnancy After Heart Transplantation. The American Journal of Cardiology, 172, 68–72. https://doi.org/10.1016/j.amjcard.2022.02.026

DeFilippis, E. M., Clerkin, K. J., Givens, R. C., Kleet, A., Rosenblum, H., O’Connell, D. C., Topkara, V. K., Bijou, R., Sayer, G., Uriel, N., Takeda, K., & Farr, M. A. (2022). Impact of socioeconomic deprivation on evaluation for heart transplantation at an urban academic medical center. Clinical Transplantation, 36(6). Portico. https://doi.org/10.1111/ctr.14652

Godown, J., Fountain, D., Bansal, N., Ameduri, R., Anderson, S., Beasley, G., Burstein, D., Knecht, K., Molina, K., Pye, S., Richmond, M., Spinner, J. A., Watanabe, K., West, S., Reinhardt, Z., Scheel, J., Urschel, S., Villa, C., & Hollander, S. A. (2022). Heart Transplantation in Children With Down Syndrome. Journal of the American Heart Association, 11(10). https://doi.org/10.1161/jaha.121.024883

Donovan, D. J., Richmond, M. E., Bacha, E. A., Addonizio, L. J., & Zuckerman, W. A. (2021). Association between homograft tissue exposure and allosensitization prior to heart transplant in patients with congenital heart disease. Pediatric Transplantation, 26(3). Portico. https://doi.org/10.1111/petr.14201

Sekulic, S. P., & Sekulic, M. (2022). Atypical arrhythmogenic presentation of giant cell myocarditis diagnosed after heart transplant. The Lancet, 399(10333), 1411. https://doi.org/10.1016/s0140-6736(22)00481-0

El-Atoum, B., Williams, M., Molina, K., Orjuela-Grimm, M. A., Prince, J., & Afify, Z. (2021). Burkitt Lymphoma After Cardiac Transplantation: Therapeutic Considerations. Journal of Pediatric Hematology/Oncology, 44(3), 100–102. https://doi.org/10.1097/mph.0000000000002260

DEFILIPPIS, E. M., PSOTKA, M. A., KHAZANIE, P., COWGER, J., & COGSWELL, R. (2022). Exploring Physician Perceptions of the 2018 United States Heart Transplant Allocation System. Journal of Cardiac Failure, 28(4), 670–674. https://doi.org/10.1016/j.cardfail.2021.11.027

Batra, J., DeFilippis, E. M., Golob, S., Clerkin, K., Topkara, V. K., Habal, M. V., Restaino, S., Griffin, J., Hi Lee, S., Latif, F., Farr, M. A., Sayer, G., Raikelkar, J., & Uriel, N. (2022). Impact of Pretransplant Malignancy on Heart Transplantation Outcomes: Contemporary United Network for Organ Sharing Analysis Amidst Evolving Cancer Therapies. Circulation: Heart Failure, 15(4). https://doi.org/10.1161/circheartfailure.121.008968

Bravo-Jaimes, K., Axsom, K., Menachem, J., Danford, D., Kutty, S., & Cedars, A. (2022). Impact of the new UNOS donor heart allocation system on waitlist outcomes and early posttransplant mortality among adults with congenital heart disease. American Journal of Transplantation, 22(4), 1123–1132. https://doi.org/10.1111/ajt.16900

Varshney, A. S., DeFilippis, E. M., Cowger, J. A., Netuka, I., Pinney, S. P., & Givertz, M. M. (2022). Trends and Outcomes of Left Ventricular Assist Device Therapy. Journal of the American College of Cardiology, 79(11), 1092–1107. https://doi.org/10.1016/j.jacc.2022.01.017

DeFilippis, E. M., Khush, K. K., Farr, M. A., Fiedler, A., Kilic, A., & Givertz, M. M. (2022). Evolving Characteristics of Heart Transplantation Donors and Recipients. Journal of the American College of Cardiology, 79(11), 1108–1123. https://doi.org/10.1016/j.jacc.2021.11.064

Topkara, V. K., Sayer, G. T., Clerkin, K. J., Wever-Pinzon, O., Takeda, K., Takayama, H., Selzman, C. H., Naka, Y., Burkhoff, D., Stehlik, J., Farr, M. A., Fang, J. C., Uriel, N., & Drakos, S. G. (2022). Recovery With Temporary Mechanical Circulatory Support While Waitlisted for Heart Transplantation. Journal of the American College of Cardiology, 79(9), 900–913. https://doi.org/10.1016/j.jacc.2021.12.022

Blitzer, D., & Copeland, H. (2022). Next steps in heart transplantation: Diagnosing and treating PGD, where are we? Journal of Cardiac Surgery, 37(5), 1299–1300. Portico. https://doi.org/10.1111/jocs.16363

Conway, J., Auerbach, S. R., Richmond, M. E., Sharp, B., Pahl, E., Feingold, B., Azeka, E., Dryer, W. J., Cantor, R. S., & Kirklin, J. K. (2022). Early report from the Pediatric Heart Transplant Society on COVID-19 infections in pediatric heart transplant candidates and recipients. The Journal of Heart and Lung Transplantation, 41(3), 327–333. https://doi.org/10.1016/j.healun.2021.11.003

Shoji, S., Kuno, T., Kohsaka, S., Amiya, E., Asleh, R., Alvarez, P., Kampaktsis, P., Staffa, S. J., Zurakowski, D., Doulamis, I., & Briasoulis, A. (2022). Incidence and long-term outcome of heart transplantation patients who develop postoperative renal failure requiring dialysis. The Journal of Heart and Lung Transplantation, 41(3), 356–364. https://doi.org/10.1016/j.healun.2021.11.017

Wu, I. Y., Wyrobek, J. A., Naka, Y., Dickstein, M. L., & Glance, L. G. (2022). Perioperative Management of Patients Receiving Short-term Mechanical Circulatory Support with the Transvalvular Heart Pump. Anesthesiology, 136(5), 829–842. https://doi.org/10.1097/aln.0000000000004124

Griffin, J. M., Baughan, E., Rosenblum, H., Clerkin, K. J., Fried, J. A., Raikhelkar, J., Uriel, N., Brannagan, T. H., Takeda, K., Grodin, J. L., Marboe, C., Maurer, M. S., & Farr, M. A. (2022). Surveillance for disease progression of transthyretin amyloidosis after heart transplantation in the era of novel disease modifying therapies. The Journal of Heart and Lung Transplantation, 41(2), 199–207. https://doi.org/10.1016/j.healun.2021.10.007

Ibeh, C., Melmed, K. R., Yuzefpolskaya, M., Colombo, P. C., & Willey, J. Z. (2022). Stroke epidemiology and outcomes in the modern era of left ventricular assist devices. Heart Failure Reviews, 27(2), 393–398. https://doi.org/10.1007/s10741-021-10201-x

Clerkin, K. J., Salako, O., Fried, J. A., Griffin, J. M., Raikhelkar, J., Jain, R., Restaino, S., Colombo, P. C., Takeda, K., Farr, M. A., Sayer, G., Uriel, N., & Topkara, V. K. (2022). Impact of Temporary Percutaneous Mechanical Circulatory Support Before Transplantation in the 2018 Heart Allocation System. JACC: Heart Failure, 10(1), 12–23. https://doi.org/10.1016/j.jchf.2021.08.003